| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J C Negrete, W P Knapp, D E Douglas, W B Smit. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological medicine. vol 16. issue 3. 1986-11-18. PMID:3489951. |
data on the history of cannabis use and a spot urine test for cannabinoids were obtained for 137 schizophrenics in treatment. |
1986-11-18 |
2023-08-11 |
human |
| E J Cone, R E Johnso. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clinical pharmacology and therapeutics. vol 40. issue 3. 1986-10-23. PMID:3017628. |
contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. |
1986-10-23 |
2023-08-11 |
human |
| C J Hillard, A S Bloom, M D Housla. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes. Biochemical pharmacology. vol 35. issue 16. 1986-09-17. PMID:3017362. |
11-oh-delta 9-thc, a psychoactive metabolite of delta 9-thc, also increased glucagon activation of adenylate cyclase while two cannabinoids without marihuana-like psychoactive potency, cannabinol and cannabidiol, did not. |
1986-09-17 |
2023-08-11 |
rat |
| G Cortis, P Luchi, M Palma. Experimental cultivation of cannabis plants in the Mediterranean area. Bulletin on narcotics. vol 37. issue 4. 1986-07-15. PMID:3011161. |
on the basis of these parameters, the authors have found that a cannabis plant in which the percentage of thc exceeds 50 per cent of the total amount of cannabinoids of the extractable resin and 0.3 per cent of the total amount of dried substance, and in which the amounts of resin and cannabinoids are substantial, has a considerable intoxicant potential and is liable to be used for illicit production of cannabis for abuse. |
1986-07-15 |
2023-08-11 |
Not clear |
| S Felby, E Nielse. Cannabinoid content of cannabis grown on the Danish island of Bornholm. Bulletin on narcotics. vol 37. issue 4. 1986-07-15. PMID:3011164. |
cannabinoid content of cannabis grown on the danish island of bornholm. |
1986-07-15 |
2023-08-11 |
Not clear |
| L E Holliste. Health aspects of cannabis. Pharmacological reviews. vol 38. issue 1. 1986-07-07. PMID:3520605. |
therapeutic uses for marijuana, thc, or cannabinoid homologs are being actively explored. |
1986-07-07 |
2023-08-11 |
Not clear |
| M J Kogan, J Al Razi, D J Pierson, N J Willso. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods. Journal of forensic sciences. vol 31. issue 2. 1986-06-27. PMID:3011956. |
urine cannabinoid assay were also positive for the major marijuana urinary metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid (thc-cooh) when assayed by gas chromatographic/mass spectrometric (gc/ms) and a noninstrumental qualitative bonded-phase adsorption/thin-layer chromatographic (bpa-tlc) technique. |
1986-06-27 |
2023-08-11 |
human |
| C Franchini, S Brun. [Polarimetric study of Cannabis sativa L. preparations: preliminary evaluation of cannabinoid content]. Bollettino chimico farmaceutico. vol 124. issue 12. 1986-06-17. PMID:3833268. |
[polarimetric study of cannabis sativa l. preparations: preliminary evaluation of cannabinoid content]. |
1986-06-17 |
2023-08-11 |
Not clear |
| M L Barrett, A M Scutt, F J Evan. Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia. vol 42. issue 4. 1986-05-22. PMID:3754224. |
cannflavin a and b, prenylated flavones from cannabis sativa l. two novel prenylated flavones, termed cannflavin a and b, were isolated from the cannabinoid free ethanolic extract of cannabis sativa l. both compounds inhibited prostaglandin e2 production by human rheumatoid synovial cells in culture. |
1986-05-22 |
2023-08-11 |
human |
| J Mørland, A Bugge, B Skuterud, A Steen, G H Wethe, T Kjeldse. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. Journal of forensic sciences. vol 30. issue 4. 1986-01-09. PMID:2999292. |
cannabinoids in blood and urine after passive inhalation of cannabis smoke. |
1986-01-09 |
2023-08-11 |
human |
| J Mørland, A Bugge, B Skuterud, A Steen, G H Wethe, T Kjeldse. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. Journal of forensic sciences. vol 30. issue 4. 1986-01-09. PMID:2999292. |
to test the possibility that cannabinoids are detectable following passive inhalation of cannabis smoke the following study was performed. |
1986-01-09 |
2023-08-11 |
human |
| J Mørland, A Bugge, B Skuterud, A Steen, G H Wethe, T Kjeldse. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. Journal of forensic sciences. vol 30. issue 4. 1986-01-09. PMID:2999292. |
it is concluded that the demonstration of cannabinoids in blood or urine is no unequivocal proof of active cannabis smoking. |
1986-01-09 |
2023-08-11 |
human |
| A P Mason, A J McBa. Cannabis: pharmacology and interpretation of effects. Journal of forensic sciences. vol 30. issue 3. 1985-10-07. PMID:2993473. |
subjects reviewed include the relative psychoactivities of cannabis constituents, the disposition and distribution of thc and its metabolites, the relative psychoactivities of thc metabolites, and the use of cannabinoid concentrations in physiological fluids in interpretations of the significance of cannabis-induced effects. |
1985-10-07 |
2023-08-11 |
human |
| R Swate. Marijuana use: persistence and urinary elimination. Journal of substance abuse treatment. vol 1. issue 4. 1985-09-03. PMID:6399325. |
using the syva emit cannabinoid assay test, a readily available semiquantitative immunochemical urine test for marijuana metabolites, a group of ten chronic marijuana users was monitored while hospitalized. |
1985-09-03 |
2023-08-12 |
Not clear |
| Y Nakahara, H Sekin. Studies on confirmation of cannabis use. I. Determination of the cannabinoid contents in marijuana cigarette, tar, and ash using high performance liquid chromatography with electrochemical detection. Journal of analytical toxicology. vol 9. issue 3. 1985-08-13. PMID:3874322. |
determination of the cannabinoid contents in marijuana cigarette, tar, and ash using high performance liquid chromatography with electrochemical detection. |
1985-08-13 |
2023-08-11 |
Not clear |
| C J Hillard, R A Harris, A S Bloo. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies. The Journal of pharmacology and experimental therapeutics. vol 232. issue 3. 1985-04-25. PMID:2983062. |
at the same concentrations, cannabidiol (cbd) and cannabinol, cannabinoids devoid of marijuana-like psychoactivity, had no effect on dph polarization. |
1985-04-25 |
2023-08-11 |
Not clear |
| A B Jones, H N ElSohly, M A ElSohl. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. V. Cross-reactivity of selected compounds in a radioimmunoassay. Journal of analytical toxicology. vol 8. issue 6. 1985-03-11. PMID:6097766. |
the degrees of cross-reactivity of 41 cannabinoids and non-cannabinoid phenolic constituents of cannabis have been determined. |
1985-03-11 |
2023-08-12 |
Not clear |
| D E Moss, G F Koob, S B McMaster, D S Janowsk. Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors. Pharmacology, biochemistry, and behavior. vol 21. issue 4. 1984-12-26. PMID:6150497. |
the behavioral effects of delta-9-tetrahydrocannabinol (thc), one of the major psychoactive cannabinoids in marijuana, were tested in two models of psychostimulant-induced behaviors in rats (locomotor behavior and stereotyped gnawing) induced by amphetamine (amph) and methylphenidate (meph). |
1984-12-26 |
2023-08-12 |
rat |
| A C Howlett, R M Flemin. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Molecular pharmacology. vol 26. issue 3. 1984-12-20. PMID:6092901. |
the inhibition of adenylate cyclase was specific for psychoactive cannabinoids, since cannabinol and cannabidiol produced minimal or no response. |
1984-12-20 |
2023-08-12 |
Not clear |
| B Law, P A Mason, A C Moffat, L J King, V Mark. Passive inhalation of cannabis smoke. The Journal of pharmacy and pharmacology. vol 36. issue 9. 1984-12-20. PMID:6149279. |
the blood samples from the passive subjects taken up to 3 h after the start of exposure to cannabis smoke showed a complete absence of cannabinoids. |
1984-12-20 |
2023-08-12 |
human |